Common Contracts
4 similar Securities Purchase Agreement contracts by Immucell Corp /De/, Transwitch Corp /De
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 15th, 2021 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 14, 2021, between ImmuCell Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 27th, 2017 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 27, 2017, between ImmuCell Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 8th, 2012 • Transwitch Corp /De • Semiconductors & related devices • New York
This Securities Purchase Agreement (this "Agreement") is dated as of May 8, 2012, between TranSwitch Corporation, a Delaware corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a "Purchaser" and collectively the "Purchasers").
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 8th, 2012 • Transwitch Corp /De • Semiconductors & related devices • New York
This Securities Purchase Agreement (this "Agreement") is dated as of May 8, 2012, between TranSwitch Corporation, a Delaware corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a "Purchaser" and collectively the "Purchasers").
